DFX Intelligence
Private Credit Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
A••• S••• L••
Pharmaceuticalsgroup grade Con a schedule nowsponsor unattributed
Principal held
at least $14.4M
sum of BDC pieces, a lower bound
Fair value
$14.0M
97c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
May 31, 2031
no dated debt inside 24 months
On the tape since
Jun 30, 2023
latest Jun 30, 2026
Events
1
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $14.4M | 97c | May 31, 2031 | 1 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| O•••••• S•••••••• L•••••• C••• | term loan first lien First Lien Term Loan | $14.4M | $14.0M 97c |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $14.4M | $14.0M | 97c | 0 |
| Mar 31, 2026 | 1 | $14.3M | $13.7M | 96c | 0 |
| Dec 31, 2025 | 1 | $14.2M | $13.6M | 96c | 0 |
| Sep 30, 2025 | 1 | $14.0M | $13.8M | 99c | 0 |
| Jun 30, 2025 | 1 | $13.8M | $13.6M | 99c | 0 |
| Mar 31, 2025 | 1 | $13.6M | $13.4M | 99c | 0 |
| Dec 31, 2024 | 1 | $13.5M | $13.2M | 98c | 0 |
| Sep 30, 2024 | 1 | $13.0M | $12.9M | 99c | 1 |
| Jun 30, 2024 | 1 | $13.6M | $13.3M | 98c | 1 |
| Mar 31, 2024 | 1 | $13.2M | $12.8M | 97c | 0 |
| Dec 31, 2023 | 1 | $12.6M | $12.3M | 97c | 0 |
| Sep 30, 2023 | 1 | $12.2M | $11.8M | 96c | 0 |
| Jun 30, 2023 | 1 | $11.7M | $11.3M | 96c | 0 |
What changed
- PIK interest appearsJun 30, 2024
- PIK interest appearsJun 30, 2024
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- A••• SPVderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Pharmaceuticalsreportedas one filer wrote it